
Please try another search
Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-100, a first in class compound with the ability to block an cancer growth enzyme, thereby disrupting the oncogenic Ras pathway. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
Ellen G. Feigal | 69 | 2023 | Independent & Non- Executive Director |
Reinhard Dummer | - | 2011 | Member of Clinical Advisory Board |
Joshua Douglas | - | 2014 | Member of Scientific Advisory Board |
Thomas Prebet | - | 2016 | Member of Scientific Advisory Board |
Farhad Ravandi | - | 2015 | Member of Scientific Advisory Board |
Jeffrey Lancet | - | 2015 | Member of Scientific Advisory Board |
Rodney Daniel Sinclair | - | 2011 | Chairman of Clinical Advisory Board |
H. Miles Prince | - | 2020 | Member of Scientific Advisory Board |
Phillip Darcy | - | 2020 | Member of Scientific Advisory Board |
Donald M. O’Rourke | - | 2021 | Member of Scientific Advisory Board |
James A. Campbell | - | 2014 | Independent Non-Executive Chairman |
Allen Ebens | - | 2020 | Non-Executive Director |
Marco L. Davila | - | 2021 | Member of Scientific Advisory Board |
Andrew Tsourkas | - | 2021 | Member of Scientific Advisory Board |
Gavin James Shepherd | - | 2024 | Independent Non-Executive Director |
Melanie Farris | - | 2025 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review